The UK Space Agency and BiologIC Technologies are partnering to develop advanced biotechnologies, including vaccines and gene therapies, for space manufacturing. The funding provided by the UKSA will support BiologIC’s research to develop and manufacture vaccines and gene therapies faster than most traditional methods and adapt those processes for space.